Bryan Ball - Net Worth and Insider Trading
Bryan Ball Net Worth
The estimated net worth of Bryan Ball is at least $878,600 dollars as of 2023-06-07. Bryan Ball is the Chief Quality Officer of Immunomedics Inc and owns about 10,000 shares of Immunomedics Inc (IMMU) stock worth over $878,600. Details can be seen in Bryan Ball's Latest Holdings Summary section.
Transaction Summary of Bryan Ball
Bryan Ball Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Bryan Ball owns 2 companies in total, including Immunomedics Inc (IMMU) , and Intercept Pharmaceuticals Inc (ICPT) .
Click here to see the complete history of Bryan Ball’s form 4 insider trades.
Insider Ownership Summary of Bryan Ball
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| IMMU | Immunomedics Inc | 2020-03-04 | Chief Quality Officer |
| ICPT | Intercept Pharmaceuticals Inc | 2021-01-11 | Chief Quality Officer |
Bryan Ball Latest Holdings Summary
Bryan Ball currently owns a total of 1 stock. Bryan Ball owns 10,000 shares of Immunomedics Inc (IMMU) as of October 3, 2019, with a value of $878,600.
Latest Holdings of Bryan Ball
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| IMMU | Immunomedics Inc | 2019-10-03 | 10,000 | 87.86 | 878,600 |
Holding Weightings of Bryan Ball
Bryan Ball Form 4 Trading Tracker
According to the SEC Form 4 filings, Bryan Ball has made a total of 2 transactions in Immunomedics Inc (IMMU) over the past 5 years, including 2 buys and 0 sells. The most-recent trade in Immunomedics Inc is the acquisition of 5,000 shares on October 3, 2019, which cost Bryan Ball around $70,900.
Insider Trading History of Bryan Ball
- 1
Bryan Ball Trading Performance
GuruFocus tracks the stock performance after each of Bryan Ball's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Bryan Ball is 32.4%. GuruFocus also compares Bryan Ball's trading performance to market benchmark return within the same time period. The performance of stocks bought by Bryan Ball within 3 months outperforms 2 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Bryan Ball's insider trading performs compared to the benchmark.
Performance of Bryan Ball
Average Relative Return
337.08%
Outperforming Transactions
100%
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Relative Return(%) | 16.89 | 32.4 | 8.52 | 337.08 | ||
| Relative Return to S&P 500(%) | 13.82 | 26.19 | 11.25 | 327.13 |
Bryan Ball Ownership Network
Ownership Network List of Bryan Ball
Ownership Network Relation of Bryan Ball
Bryan Ball Owned Company Details
What does Immunomedics Inc do?
Immunomedics Inc is a clinical-stage biopharmaceutical company, based in the United States. The company develops monoclonal antibody-based products for the targeted treatment of cancer and autoimmune disorders, among others. Its portfolio of products under investigation include antibody-drug conjugates that target the tumor-reducing toxic effects of chemotherapeutic treatments. The company's pipeline includes products targeting solid tumors and hematologic malignancies, among other diseases in clinical and preclinical development. The company is marketing specific diagnostic imaging agents to detect bone infections in Europe, Canada, and Australia. The company has subsidiaries in the Netherlands and Germany to manage sales and clinical trials in Europe.
Who are the key executives at Immunomedics Inc?
Bryan Ball is the Chief Quality Officer of Immunomedics Inc. Other key executives at Immunomedics Inc include director & 10 percent owner & other: See Remarks Venbio Select Advisor Llc , director & 10 percent owner & other: See Remarks Behzad Aghazadeh , and director & President and CEO Harout Semerjian .
Immunomedics Inc (IMMU) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Immunomedics Inc (IMMU) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Immunomedics Inc (IMMU) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Immunomedics Inc (IMMU)'s detailed insider trading history can be found in Insider Trading Tracker table.
Immunomedics Inc Insider Transactions
Bryan Ball Mailing Address
Above is the net worth, insider trading, and ownership report for Bryan Ball. You might contact Bryan Ball via mailing address: 300 The American Road, Morris Plains Nj 07950.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
